| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99233 |
Prolong inpt eval add15 m |
14,039 |
6,511 |
$820K |
| 90960 |
End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits |
10,788 |
8,578 |
$791K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
23,178 |
9,535 |
$719K |
| 90961 |
|
3,537 |
2,891 |
$176K |
| 36902 |
|
1,061 |
900 |
$138K |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
1,502 |
603 |
$42K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
869 |
707 |
$38K |
| 99223 |
Prolong inpt eval add15 m |
296 |
239 |
$27K |
| 99215 |
Prolong outpt/office vis |
512 |
302 |
$18K |
| 99152 |
|
591 |
483 |
$5K |
| 90966 |
|
112 |
91 |
$5K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
315 |
143 |
$1K |
| 90962 |
|
39 |
28 |
$740.48 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
402 |
356 |
$714.96 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
636 |
409 |
$46.18 |
| G9500 |
Radiation exposure indices documented in final report for procedure using fluoroscopy |
1,274 |
1,122 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
127 |
118 |
$0.00 |